A method of quantification for the evaluation of antiepileptic drug therapy
- 1 March 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 33 (3_suppl_1) , 26-37
- https://doi.org/10.1212/wnl.33.3_suppl_1.26
Abstract
The design of clinical trials of antiepileptic drugs should include explicit methods for numeric quantification of seizures and side effects. Rating scales were developed to assess frequency and severity of seizures (partial and generalized tonic-clonic), systemic toxicity, and neurotoxicity. These scales are combined to form a single composite rating that reflects the overall effect of the drug on the patient. The rating system can be adapted to compare efficacy and toxicity of any antiepileptic drugs, for any types of seizures.This publication has 9 references indexed in Scilit:
- A design for the prospective evaluation of the efficacy and toxicity of antiepileptic drugs in adultsNeurology, 1983
- Carbamazepine vs PhenytoinArchives of Neurology, 1979
- Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- Carbamazepine—A double‐blind comparison with phenytoinNeurology, 1977
- Eterobarb therapy in epilepsyNeurology, 1976
- Further observations on carbamazepine plasma levels in epileptic patientsNeurology, 1976
- ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSYThe Lancet, 1976
- Relative Anticonvulsant Potency of PrimidoneArchives of Neurology, 1966
- OBJECTIVE COMPARISON OF PRIMIDONE AND PHENOBARBITAL IN EPILEPTICS1957